Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.37 USD | -2.46% | -2.89% | -14.98% |
Financials (USD)
Sales 2024 * | 1.07M | Sales 2025 * | 200K | Capitalization | 118M |
---|---|---|---|---|---|
Net income 2024 * | -30M | Net income 2025 * | -61M | EV / Sales 2024 * | 3.75 x |
Net cash position 2024 * | 114M | Net cash position 2025 * | 60.6M | EV / Sales 2025 * | 288 x |
P/E ratio 2024 * |
-2.74
x | P/E ratio 2025 * |
-2.23
x | Employees | 37 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.79% |
Latest transcript on Vistagen Therapeutics, Inc.
1 day | -2.46% | ||
1 week | -2.89% | ||
Current month | -9.52% | ||
1 month | -10.63% | ||
3 months | -15.15% | ||
6 months | +70.04% | ||
Current year | -14.98% |
Managers | Title | Age | Since |
---|---|---|---|
Shawn Singh
CEO | Chief Executive Officer | 61 | 99-12-31 |
Cynthia Anderson
DFI | Director of Finance/CFO | 55 | 23-08-20 |
Joshua Prince
COO | Chief Operating Officer | 54 | 21-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jon Saxe
BRD | Director/Board Member | 88 | 00-05-31 |
Jerry Gin
BRD | Director/Board Member | 81 | 16-02-29 |
Shawn Singh
CEO | Chief Executive Officer | 61 | 99-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 0 M€ | +4.20% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 4.37 | -2.46% | 106,543 |
24-05-09 | 4.48 | +0.67% | 153,524 |
24-05-08 | 4.45 | -4.51% | 115,727 |
24-05-07 | 4.66 | +0.87% | 135,234 |
24-05-06 | 4.62 | +2.67% | 110,456 |
Delayed Quote Nasdaq, May 10, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.98% | 118M | |
+3.91% | 109B | |
+10.87% | 105B | |
+1.28% | 22.25B | |
-13.14% | 22.09B | |
-7.05% | 18.68B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B |
- Stock Market
- Equities
- VTGN Stock